コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ealth often deteriorates during reproductive aging.
2 tion contributes to inflammation, cancer and aging.
3 pproach for studying its role in disease and aging.
4 ansformation of stem cells that characterize aging.
5 might further clarify the prognostic role of aging.
6 ants for 12-36 h to allow oocytes to undergo aging.
7 stable pigments during fermentation and wine aging.
8 ls, renal function gradually declines during aging.
9 bryonic development, disease progression and aging.
10 identify mechanisms underlying physiological aging.
11 portant roles in neurodegeneration and brain aging.
12 eage commitment was radiation sensitive with aging.
13 rogenitor cells, and in preventing premature aging.
14 heir genetic clearance can delay features of aging.
15 of skeletal muscle, is important for healthy aging.
16 he canopy of central African forests are now aging.
17 e trend of variation with the endplate after aging.
18 tabolism might also have a role in mammalian aging.
19 ing an increase in methylome disorder during aging.
20 esized by NSCs and increases in the SGZ with aging.
21 midbrain dopaminergic neurons (mDANs) during aging.
22 loped countries, is strongly associated with aging.
23 ce of the microbiome, and how they relate to aging.
24 o genotoxic stress and confer fitness during aging.
25 s of dopaminergic neurons over the course of aging.
26 rogen sulfide and other mercaptans during AR-aging.
27 foundation for rejuvenating immunity during aging.
28 ation and tissue atrophy, and in accelerated aging.
29 ve oxygen species metabolism and accelerated aging.
30 a and impaired epidermal stratification upon aging.
31 d pathways may potentially alter the rate of aging.
32 ociated epigenetic changes are implicated in aging.
33 ibutes to developmental defects, cancer, and aging.
34 d genetic mechanisms that control organismal aging.
35 tic brain injury, prolonged wakefulness, and aging.
36 are independent signals for cellularity and aging.
37 a variety of human diseases as well as human aging.
38 reatment of infections and malignancy during aging.
39 gmentation is a critical determinant of skin aging.
40 in the population-based Mayo Clinic Study of Aging.
41 stress resemble trajectories observed during aging.
42 germ line predisposition, inflammation, and aging.
43 alization reverses the behavioral effects of aging.
44 rk in the endplate and the interaction after aging.
45 in metabolic disease, neurodegeneration, and aging.
46 traviolet A (TMP/UVA) during development and aging.
47 ion on retinal structure and function during aging.
48 o be associated with overall cancer risk and aging.
49 h may protect against cancer, radiation, and aging.
50 is regarded as a disease of accelerated lung aging.
51 molecular mechanisms that contribute to HSC aging.
52 or [3], and alterations in processes such as aging [4] and brain disorders [5], highlighting the impo
54 articipants were in the Mayo Clinic Study of Aging, a population-based study that uses a medical reco
55 tanding mechanisms of SC maintenance and how aging affects SC function are of special importance, bot
56 , and humans that demonstrates how cognitive aging affects the navigational computations supported by
57 earning and memory, the review discusses how aging affects the perception and integration of spatial
59 hology according to US National Institute on Aging-Alzheimer's Association neuropathological criteria
61 ed our technology to quantify the effects of aging and age-related genetic and chemical factors in th
62 Oregon Health and Science University Layton Aging and Alzheimer Disease Center and Oregon Brain Bank
64 ice had reduced macrophage infiltration with aging and CalpTG mice produced less IL-1alpha and IL-1be
65 evidence supports a general hypothesis that aging and cancer are diseases related to energy metaboli
68 se activity, which accelerated the molecular aging and clearance of intestinal alkaline phosphatase (
69 has uncovered genetic contributions to skin aging and confirmed previous findings, showing that pigm
71 tential for organoids to serve as models for aging and describe how current organoid techniques could
72 cs, i.e., energy metabolism, occur in normal aging and disturbed bioenergetics may be an important co
73 ion, increases most aspects of health during aging and extends lifespan in diverse species, including
74 between reproductive senescence and somatic aging and give an overview of the involvement of nutrien
75 formance is affected by neurodegeneration in aging and has the potential to be used as a clinical mar
76 onal design of small molecules that modulate aging and hence alter the propensity for a host of age-r
77 e changes in tissue structure seen in normal aging and in chronic inflammation to altered lung mechan
78 progressive process affecting kidneys during aging and in chronic kidney disease (CKD), regardless of
79 imaging during microvascular development and aging and in models of brain ischemia and Alzheimer's di
82 rotein aggregates, which are associated with aging and many human diseases such as Alzheimer's diseas
83 abnormalities, genomic instability, and HSC aging and might promote hematological malignancies with
84 diac hypertrophy induced by stresses such as aging and neurohumoral activation is an independent risk
85 g 28 y in the Swedish Adoption/Twin Study of Aging and parental social class based on the Swedish soc
87 l which incorporates genetic effect, natural aging and prolonged oral environmental toxicity administ
88 Our results suggest that both biological aging and reduced regenerative capacity contribute to ca
89 MPP phenotypes are reminiscent of premature aging and stressed hematopoiesis, and indeed progressed
90 depleted glutathione levels, which occur in aging and stroke, will give rise to dysfunctional CBF re
91 lial cells (ECs) in regulating hematopoietic aging and support further research to identify the rejuv
92 -driver mutations (CHDMs) occurs with normal aging and these mutations have been detected in more tha
94 mitophagy is thought to contribute to normal aging and to various neurodegenerative and cardiovascula
96 Alzheimer's disease (AD), it also occurs in aging and various neurological, medical, and psychiatric
97 are also able to demonstrate that epigenetic aging and white matter tract integrity also share common
101 betes, obesity, neurodegenerative disorders, aging, and cancer, making the TOR pathway an attractive
103 three of the main regulators of metabolism, aging, and longevity, are components of the same pathway
104 y.A cross-sectional subset of the Nutrition, Aging, and Memory in Elders cohort who had undergone MRI
105 es, regeneration of tissues, cell divisions, aging, and pathological conditions observed in many canc
107 ular process can directly influence cellular aging, and thus could provide guidance for the design of
108 e further subjected to Accelerated Reductive aging (AR) and analyzed for free and Brine Releasable (B
109 sms underlying altered beta-cell function in aging are poorly understood in mouse and human islets, a
116 tes from the Baltimore Longitudinal Study of Aging (BLSA) to determine whether impaired mitochondrial
118 ption may be one key factor that renders the aging brain vulnerable to Abeta deposition and the devel
119 could imply loss of cellular identity in the aging brain, and provide a link between aging-related mo
121 nctional mitochondria has been implicated in aging, but a deeper understanding of mitochondrial dynam
122 on has been associated with many diseases of aging, but the mechanisms responsible for producing this
125 California, San Francisco (UCSF) Memory and Aging Center (collected between 1999-2015) and 11,381 in
127 f Foxp1 in bone marrow MSCs led to premature aging characteristics, including increased bone marrow a
128 d up participants with HIV from the Veterans Aging Cohort Study for a minimum of 3 years between Jan
143 Our data indicate that redistribution of aging factors from aged cells to their progeny can be a
146 ss of ISCs coupled with tissue demand and in aging flies, underscoring the generality of this mechani
148 ic Epidemiology Research on Adult Health and Aging (GERA) cohort individuals provided 1,342,814 systo
149 ic Epidemiology Research in Adult Health and Aging (GERA) cohort, in four race/ethnicity groups: non-
152 ve dysfunction in normative and pathological aging has been linked to hyperexcitability in the aged C
159 eets generated with long-term passaged (P10) aging human mesenchymal stromal cells (MSCs) could be us
161 that extensive long-term culture-induced MSC aging impaired their osteogenic ability and subsequent b
165 upling is impaired as a consequence of brain aging in later life, contributing to cognitive and memor
167 typic systems that recapitulate hallmarks of aging in order to better understand and to modulate the
168 tive assessments of age-related trends after aging, including mean diameter, volume fraction and conn
169 his affliction shows all of the hallmarks of aging, including telomere shortening, cellular senescenc
171 f numerous molecular changes associated with aging, insights into the driver mechanisms of this funda
172 oxical findings that aging itself and slowed aging interventions can both be characterized by slower
175 fore, that chronological resistance arterial aging is a prominent factor leading to weakened vasodila
178 fining the structure of the notochord during aging is critical for investigations relating to IVD fun
180 The generally accepted paradigm is that such aging is gradual and its origin is in slower than expone
183 t an early stage of differentiation and that aging is not an obligate requirement for a CD19(neg) sta
185 ry signaling and microglial sensitization in aging, its implications in psychological stress, and int
186 nt may explain the paradoxical findings that aging itself and slowed aging interventions can both be
188 ersely, psychological stress may also induce aging-like sensitization of microglia and increase react
190 levels were positively associated with skin aging manifestation, including score of pigment spots on
193 nal data suggest that accelerated biological aging may be a mechanism through which sleep influences
194 pulation is widely promoted as 0.8 g . d(-1) Aging may increase protein requirements, particularly to
195 ns in some elderly subjects, indicating that aging may negatively affect the ability of B cells to di
196 e often-reported posterior-anterior shift in aging may not reflect a global sensory-processing defici
197 ing function, which is found in normal brain aging, may play an important role in the pathogenesis of
198 he associations of adult height with healthy aging measured by a full spectrum of health outcomes, in
199 mportance of skeletal muscle inflammation in aging-mediated insulin resistance, and our findings furt
202 s Consortium (ADGC), a National Institute on Aging (NIA)-funded national data repository (reflecting
203 ause both proteins are expressed in normally aging non-HGPS individuals, and most hallmarks of normal
205 an alternative, but many functional signs of aging occur at the level of tissues rather than cells an
206 PS individuals, and most hallmarks of normal aging occur in progeria, research on HGPS can identify m
207 We observe noise reduction during normal aging of a cell, followed by a short catastrophe phase i
210 aged HSCs to thrombin-cleaved OPN attenuates aging of old HSCs, resulting in increased engraftment, d
211 e of the enzyme acid sphingomyelinase in the aging of stored units of packed red blood cells (pRBCs)
213 n, maintenance, neuromuscular disorders, and aging of the NMJ, focusing on communications among moton
215 ients and health care systems, and given the aging of the population worldwide, the incidence of fall
216 ere, we provide an overview of the impact of aging on both the allograft and the recipient and its ef
217 ponents of immunity, including the effect of aging on cells of the (mostly adaptive) immune system, o
218 in mouse and human islets, and the impact of aging on intraislet communication has not been character
220 xt for understanding how feedback altered by aging or injuries may influence the ability to regulate
221 To enquire how the circadian system protects aging organisms, here we compare circadian transcriptome
222 of the supportive housing program for youths aging out of foster care and the need for such programs
227 lantation and will likely increase given the aging population and nonalcoholic fatty liver disease as
229 rates of adult obesity and DM along with an aging population, NAFLD-related liver disease and mortal
230 cular event affecting most individuals in an aging population, there is little consensus regarding it
231 pose an extraordinary threat to the world's aging population, yet no disease-modifying therapies are
239 aging, research suggests that targeting the aging process itself could ameliorate many age-related p
247 sis, and report that nucleoli also expand as aging progresses in cells derived from healthy individua
251 ldwide highlights the need to understand how aging promotes CVD in order to develop new strategies to
256 a new therapeutic approach for obesity- and aging-related diseases associated with mitochondrial dys
258 the aging brain, and provide a link between aging-related molecular changes and functional decline.
260 n of Pofut1 in skeletal myofibers can induce aging-related phenotypes in cis within skeletal myofiber
262 tain proteostasis undergoes a decline during aging, rendering the organism susceptible to these patho
263 the two and that synaptic homeostasis during aging requires autophagy to regulate protein homeostasis
264 Proteostasis is one of the seven "pillars of aging research" identified by the Trans-NIH Geroscience
266 r from understanding the biological basis of aging, research suggests that targeting the aging proces
268 rging themes, including the contributions of aging, selective vulnerability and non-cell-autonomous f
270 ach with a number of murine models of slowed aging shows that, compared to controls, energetic resour
274 health also helps move more industrialized, aging societies from a focus on material consumption to
276 an increase in immunological tolerance with aging suppresses disease onset after late young adulthoo
277 in protection is more likely associated with aging than the virus infection and could be compensated
278 discuss CRTC deregulation as a new driver of aging that integrates the link between age and disease r
279 Telomere length is a marker of biological aging that may provide a cellular memory of exposures to
283 nditions that are characteristic of the mice aging, the function of Roquin was examined in immune cel
284 coupling of cellular, tissue, and organismal aging through inhibition of ISC proliferation and provid
286 ndicate that dissolution, concentration, and aging time are important factors that influence Cu extra
290 rain networks during progression from normal aging to Alzheimer disease dementia (AD) has also been o
291 se findings broaden the concept of cognitive aging to include evidence of Alzheimer's disease-related
292 85146 near SLC45A2 is associated with a skin aging trait at genome-wide significance (P = 4.1 x 10(-9
293 ased studies, the NHATS (National Health and Aging Trends Study) linked to the NSOC (National Study o
294 mimics a form of accelerated cardiovascular aging, we also studied age-related cardiac remodeling.
295 show that human islet function declines with aging, which can reduce insulin action and may contribut
296 stulated to play a role on sarcopenia during aging, which is believed to be due alterations in glucos
297 ssociation of epigenetic age and immune cell aging with sleep in the Women's Health Initiative study
299 e (21% vs. 31% and 49%, respectively) and an aging workforce that is less likely to be in private pra
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。